Welcome to Tacoma Vet Medications
Sale!

AL Namoos

$50.00

Sale!

AL Namoos crowning podium is a vet product used to for so many purpose and is also help with intra muscular Analgesic nephropathy is a common adverse effect of NSAIDs in animal ever, it does not occur as often in domestic animals, in part because the drugs are not used as chronically. In the kidney, AL Namoos vasodilating prostaglandins are protective, ensuring arterial and renal vasoconstriction. The loss of this protective effect becomes important in patients with impaired renal function. Patients predisposed to analgesic nephropathy include geriatric patients, patients suffering from heart, kidney or liver disease, patients in hypovolemic states (shock and dehydration), and patients receiving nephrotoxic (aminoglycosides, for example) or nephroactive (diuretic) drugs. Care must be taken to avoid intra-arterial drug administration. If wrongly applied, there may be stimulation of the Central Nervous System (CNS), occurring hysteria, ataxia, AL Namooshyperventilation and muscle weakness, in which these symptoms are transient and do not require any control measures. AL NamoosContraindications: The product must not be applied by any route other than intramuscular or intravenous. Do not administer the product to animals with a history of hypersensitivity to non-steroidal anti-inflammatory drugs. Do not use medicines that have expired. Do not use in animals with gastrointestinal ulceration, severe cardiac damage, renal or hepatic impairment, or those with evidence of haematological disorder. Storage conditions: Store in a dry and cool place, at room temperature between 15 °C and 30 °C, away from sunlight, out of reach of children and pets. Use the product within 30 days after the first application. Attention – Grace Period: Horses: The product should not be administered to horses destined for

Reviews

There are no reviews yet.

Be the first to review “AL Namoos”

Your email address will not be published. Required fields are marked *

You cannot copy content of this page